These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 34564380)

  • 21. Variable phenotypic expression of homozygous familial hypobetalipoproteinaemia due to novel APOB gene mutations.
    Di Leo E; Magnolo L; Bertolotti M; Bourbon M; Carmo Pereira S; Pirisi M; Calandra S; Tarugi P
    Clin Genet; 2008 Sep; 74(3):267-73. PubMed ID: 18492086
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolism of apolipoprotein B-100 in a kindred with familial hypobetalipoproteinemia without a truncated form of apoB.
    Latour MA; Patterson BW; Pulai J; Chen Z; Schonfeld G
    J Lipid Res; 1997 Mar; 38(3):592-9. PubMed ID: 9101440
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Familial hypobetalipoproteinemia: analysis of three Spanish cases with two new mutations in the APOB gene.
    Martín-Morales R; García-Díaz JD; Tarugi P; González-Santos P; Saavedra-Vallejo P; Magnolo L; Mesa-Latorre JM; di Leo E; Valdivielso P
    Gene; 2013 Nov; 531(1):92-6. PubMed ID: 24001780
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel missense variants in LCAT and APOB genes in an Italian kindred with familial lecithin:cholesterol acyltransferase deficiency and hypobetalipoproteinemia.
    Conca P; Pileggi S; Simonelli S; Boer E; Boscutti G; Magnolo L; Tarugi P; Penco S; Franceschini G; Calabresi L; Gomaraschi M
    J Clin Lipidol; 2012; 6(3):244-50. PubMed ID: 22658148
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Familial hypobetalipoproteinemia: genetics and metabolism.
    Schonfeld G; Lin X; Yue P
    Cell Mol Life Sci; 2005 Jun; 62(12):1372-8. PubMed ID: 15818469
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Absence of fatty liver in familial hypobetalipoproteinemia linked to chromosome 3p21.
    Yue P; Tanoli T; Wilhelm O; Patterson B; Yablonskiy D; Schonfeld G
    Metabolism; 2005 May; 54(5):682-8. PubMed ID: 15877300
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lipoprotein metabolism in an apoB-80 familial hypobetalipoproteinemia heterozygote.
    Hooper AJ; Robertson K; Champain D; Hua J; Song S; Parhofer KG; Barrett PHR; van Bockxmeer FM; Burnett JR
    Clin Biochem; 2016 Jun; 49(9):720-722. PubMed ID: 26916057
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Homozygous familial hypobetalipoproteinemia: A Turkish case carrying a missense mutation in apolipoprotein B.
    Yilmaz BS; Mungan NO; Di Leo E; Magnolo L; Artuso L; Bernardis I; Tumgor G; Kor D; Tarugi P
    Clin Chim Acta; 2016 Jan; 452():185-90. PubMed ID: 26612772
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Postprandial lipoprotein metabolism in familial hypobetalipoproteinemia.
    Hooper AJ; Robertson K; Barrett PH; Parhofer KG; van Bockxmeer FM; Burnett JR
    J Clin Endocrinol Metab; 2007 Apr; 92(4):1474-8. PubMed ID: 17213276
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Homozygous familial hypobetalipoproteinemia caused by APOB gene variations: a case report and review of literature].
    Zhang YQ; Wang JS
    Zhonghua Er Ke Za Zhi; 2023 Jan; 61(1):70-75. PubMed ID: 36594125
    [No Abstract]   [Full Text] [Related]  

  • 31. Pediatric gallstone disease in familial hypobetalipoproteinemia.
    Lancellotti S; Zaffanello M; Di Leo E; Costa L; Lonardo A; Tarugi P
    J Hepatol; 2005 Jul; 43(1):188-91. PubMed ID: 15894400
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro functional characterization of splicing variants of the APOB gene found in familial hypobetalipoproteinemia.
    Rabacchi C; Simone ML; Pisciotta L; Di Leo E; Bocchi D; Pietrangelo A; D'Addato S; Bertolini S; Calandra S; Tarugi P
    J Clin Lipidol; 2019; 13(6):960-969. PubMed ID: 31629702
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical and biochemical characteristics of individuals with low cholesterol syndromes: A comparison between familial hypobetalipoproteinemia and familial combined hypolipidemia.
    Di Costanzo A; Di Leo E; Noto D; Cefalù AB; Minicocci I; Polito L; D'Erasmo L; Cantisani V; Spina R; Tarugi P; Averna M; Arca M
    J Clin Lipidol; 2017; 11(5):1234-1242. PubMed ID: 28733173
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic heterogeneity in familial hypobetalipoproteinemia: linkage and non-linkage to the apoB gene in Caucasian families.
    Pulai JI; Neuman RJ; Groenewegen AW; Wu J; Schonfeld G
    Am J Med Genet; 1998 Feb; 76(1):79-86. PubMed ID: 9508071
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Janus-faced manifestations of homozygous familial hypobetalipoproteinemia due to apolipoprotein B truncations.
    Di Leo E; Eminoglu T; Magnolo L; Bolkent MG; Tümer L; Okur I; Tarugi P
    J Clin Lipidol; 2015; 9(3):400-5. PubMed ID: 26073401
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional analysis of two novel splice site mutations of APOB gene in familial hypobetalipoproteinemia.
    Di Leo E; Magnolo L; Pinotti E; Martini S; Cortella I; Vitturi N; Rabacchi C; Wunsch A; Pucci F; Bertolini S; Calandra S; Tarugi P
    Mol Genet Metab; 2009 Feb; 96(2):66-72. PubMed ID: 19084451
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between familial hypobetalipoproteinemia and the risk of diabetes. Is this the other side of the cholesterol-diabetes connection? A systematic review of literature.
    Noto D; Arca M; Tarugi P; Cefalù AB; Barbagallo CM; Averna MR
    Acta Diabetol; 2017 Feb; 54(2):111-122. PubMed ID: 27804036
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The c.43_44insCTG variation in PCSK9 is associated with low plasma LDL-cholesterol in a Caucasian population.
    Yue P; Averna M; Lin X; Schonfeld G
    Hum Mutat; 2006 May; 27(5):460-6. PubMed ID: 16619215
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Abnormal apolipoprotein B pre-mRNA splicing in patients with familial hypobetalipoproteinaemia.
    Di Leo E; Magnolo L; Lancellotti S; Crocè L; Visintin L; Tiribelli C; Bertolini S; Calandra S; Tarugi P
    J Med Genet; 2007 Mar; 44(3):219-24. PubMed ID: 17158591
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PCSK9 dominant negative mutant results in increased LDL catabolic rate and familial hypobetalipoproteinemia.
    Cariou B; Ouguerram K; Zaïr Y; Guerois R; Langhi C; Kourimate S; Benoit I; Le May C; Gayet C; Belabbas K; Dufernez F; Chétiveaux M; Tarugi P; Krempf M; Benlian P; Costet P
    Arterioscler Thromb Vasc Biol; 2009 Dec; 29(12):2191-7. PubMed ID: 19762784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.